Park Avenue

Yield10 Bioscience Announces Closing of $3.7 Million Public Offering

Retrieved on: 
Tuesday, August 15, 2023
Attention, Telephone, Park Avenue, Free File, Sale, Suite, Yield10 Bioscience, Prospectus, Form, Security (finance)

WOBURN, Mass., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced the closing of its previously announced public offering of 5,750,000 units at a public offering price of $0.65 per unit.

Key Points: 
  • WOBURN, Mass., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced the closing of its previously announced public offering of 5,750,000 units at a public offering price of $0.65 per unit.
  • Gross proceeds, before deducting placement agent fees and other offering expenses, were approximately $3.7 million.
  • Maxim Group LLC and Lake Street Capital Markets, LLC acted as joint placement agents for the offering.
  • A final prospectus relating to and describing the terms of the public offering was filed with the SEC.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Infinity Pharmaceuticals, Inc. (INFI) Investors

Retrieved on: 
Thursday, August 17, 2023
Class Action Lawsuit, Professional Services, Legal, Park Avenue, Head, Neck, Suite, Investment, Infinity, Defendant, Court, MEI, Hand, GPM, News, Breast cancer, Security (finance), Cryptocurrency, Webcast

The proposed transaction was all stock, pursuant to which Infinity shareholders would receive shares of MEI common stock.

Key Points: 
  • The proposed transaction was all stock, pursuant to which Infinity shareholders would receive shares of MEI common stock.
  • Infinity would become a wholly-owned subsidiary of MEI, with outstanding equity post-closing being held 58% by MEI shareholders and 42% by Infinity shareholders.
  • The following day, on extraordinary volume of over 3 million shares, Infinity stock lost half its volume, closing at $0.28 per share.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

DR. HOWARD SOBEL PIONEERS NEW HAIR REJUVENATION APPROACH AT SOBEL SKIN

Retrieved on: 
Monday, August 14, 2023
Hair, Hair loss, Skin, Park Avenue, Woman, Scalp, COVID, Cell, Static pressure, Plasma, Dermatology, Laser, PRP, Blood, Sobel, Cosmetics

NEW YORK, Aug. 14, 2023 /PRNewswire/ -- Leading New York City dermatologist, Howard Sobel M.D. announces a breakthrough new offering in the fight against hair loss with the new Alma TED (TransEpidermal Delivery) treatment at Sobel Skin. The American Hair Loss Association estimates that more than 80 million men and women are suffering from hair loss in the US, an increase of 400% since 2019. And while it's normal to shed up to 100 hairs a day, lifestyle choices and generics can play a negative role when it comes to speeding up hair loss and thinning, particularly post COVID.

Key Points: 
  • announces a breakthrough new offering in the fight against hair loss with the new Alma TED (TransEpidermal Delivery) treatment at Sobel Skin.
  • The American Hair Loss Association estimates that more than 80 million men and women are suffering from hair loss in the US, an increase of 400% since 2019.
  • "The painless 20–30-minute procedure instantly addresses thinning hair concerns while reducing hair shedding and loss through sound waves that improve blood flow to the scalp, signaling hair follicles to produce thicker, stronger hair," adds Dr. Sobel.
  • As the premier aesthetic dermatology center in New York, Sobel Skin delivers the latest advancements in dermatology, cosmetic surgery, and aesthetic medicine.

Yield10 Bioscience Announces Pricing of $3.7 Million Public Offering

Retrieved on: 
Friday, August 11, 2023
Attention, Telephone, Park Avenue, Free File, Sale, Suite, Yield10 Bioscience, Form S-1, Prospectus, Form, Security (finance)

WOBURN, Mass., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced the pricing of its public offering of 5,750,000 units at a public offering price of $0.65 per unit.

Key Points: 
  • WOBURN, Mass., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced the pricing of its public offering of 5,750,000 units at a public offering price of $0.65 per unit.
  • Gross proceeds, before deducting placement agent fees and other offering expenses, are expected to be approximately $3.7 million.
  • The offering is expected to close on or about August 15, 2023, subject to the satisfaction of customary closing conditions.
  • A final prospectus relating to and describing the terms of the public offering will be filed with the SEC.

Imperial Petroleum Inc. Announces Pricing of Approximately $17.0 Million Registered Direct Offering

Retrieved on: 
Friday, August 11, 2023
Attention, Telephone, Park Avenue, United States v. Imperial Petroleum, Inc., SEC filing, IMPP, Sale, Prospectus, Form, Security (finance)

Maxim Group LLC is acting as the sole placement agent in connection with the offering.

Key Points: 
  • Maxim Group LLC is acting as the sole placement agent in connection with the offering.
  • The offering is expected to close on or about August 15, 2023, subject to the satisfaction of customary closing conditions.
  • The offering will be made only by means of a prospectus supplement that forms a part of such registration statement.
  • A prospectus supplement relating to the offering will be filed by Imperial Petroleum Inc. with the SEC.

AVAIO Digital Partners Welcomes Thomas Nesel

Retrieved on: 
Wednesday, August 9, 2023
KPI, JPMorgan Chase, Engineering, Harvard University, Environmental science, GlobalFoundries, AECOM, Park Avenue, Risk management, Institute of Environmental Sciences and Engineering, Synthase, Waterline Square, Vanderbilt, CM, Construction management, Artificial intelligence, Retail

STAMFORD, Conn., Aug. 9, 2023 /PRNewswire/ -- AVAIO Digital Partners (AVAIO Digital), a data center business developing sustainable hyperscale data centers in North America and Europe, welcomes Thomas Nesel as a Project Manager with expertise in construction management and manufacturing engineering. Tom joins the AVAIO Digital team to oversee the company's operational processes and controls across its portfolio and to help lead AVAIO Digital's multi-continent data center projects through the development process from entitlement and design to permitting and through construction into operation.

Key Points: 
  • STAMFORD, Conn., Aug. 9, 2023 /PRNewswire/ -- AVAIO Digital Partners (AVAIO Digital) , a data center business developing sustainable hyperscale data centers in North America and Europe, welcomes Thomas Nesel as a Project Manager with expertise in construction management and manufacturing engineering.
  • "We're extremely excited about the unique expertise across real estate, manufacturing and engineering that Tom brings to his role at AVAIO Digital," remarks Laurance Lewis, Chief Commercial Officer of AVAIO Digital.
  • AVAIO Digital currently has sites under development in four countries across North America and Europe, with several additional sites under negotiation.
  • To learn more about AVAIO Digital Partners, click here .

Oaktree Specialty Lending Corporation Prices Public Offering of $300,000,000 7.100% Notes due 2029

Retrieved on: 
Tuesday, August 8, 2023
Vesey Street, ATTN:, Keefe, Bruyette & Woods, Market, The 8th Floor, Oppenheimer, Barclays Capital Inc. v. Theflyonthewall.com, Inc., Park Avenue, BofA Securities, SMBC Nikko Securities, J.P. Morgan & Co., Goldman Sachs, Sale, Brookfield Place, RBC Capital Markets, BNP Paribas, Prospectus, Jefferies Group, Wells Fargo, Madison Avenue, CIBC, Security (finance)

LOS ANGELES, CA, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Oaktree Specialty Lending Corporation (NASDAQ: OCSL) (“OCSL” or the “Company”), a specialty finance company, today announced that it has priced an underwritten public offering of $300.0 million aggregate principal amount of 7.100% notes due 2029.

Key Points: 
  • LOS ANGELES, CA, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Oaktree Specialty Lending Corporation (NASDAQ: OCSL) (“OCSL” or the “Company”), a specialty finance company, today announced that it has priced an underwritten public offering of $300.0 million aggregate principal amount of 7.100% notes due 2029.
  • OCSL expects to use the net proceeds of this offering to reduce its outstanding debt under its revolving credit facilities and for general corporate purposes.
  • BofA Securities, Inc., RBC Capital Markets, LLC, J.P. Morgan Securities LLC, and SMBC Nikko Securities America, Inc. are acting as joint book-running managers for this offering.
  • The offering may be made only by means of a preliminary prospectus supplement and an accompanying prospectus.

Tivic Health Announces Pricing of $1.4 Million Public Offering of Common Stock

Retrieved on: 
Sunday, August 6, 2023
Biotechnology, Health Technology, Health, Telephone, System, Attention, Form, Sale, Park Avenue, Prospectus, SEC filing, S-3, Security (finance)

Tivic Health® Systems, Inc. (“Tivic”, “Company”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced the pricing of its previously announced public offering of 33,173,000 shares of its common stock at a public offering price of $0.041 per share.

Key Points: 
  • Tivic Health® Systems, Inc. (“Tivic”, “Company”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced the pricing of its previously announced public offering of 33,173,000 shares of its common stock at a public offering price of $0.041 per share.
  • Gross proceeds from the offering are expected to be approximately $1.4 million before deducting placement agent fees and estimated offering expenses.
  • Tivic intends to use the net proceeds of the offering for working capital and general corporate purposes.
  • A preliminary prospectus supplement and the accompanying prospectus relating to and describing the terms of the public offering have been filed with the SEC.

Tivic Health Announces Proposed Public Offering of Common Stock

Retrieved on: 
Friday, August 4, 2023
General Health, Health Technology, Health, Medical Devices, Telephone, Form, Attention, Sale, Park Avenue, Prospectus, Proofpoint Systems, Inc., Public access file, S-3, Security (finance)

Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that it intends to offer and sell shares of its common stock in a public offering.

Key Points: 
  • Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that it intends to offer and sell shares of its common stock in a public offering.
  • All of the shares of common stock are being offered by Tivic.
  • Tivic intends to use the net proceeds of the offering, if any, for working capital and general corporate purposes.
  • Before you invest, you should read the preliminary prospectus supplement and accompanying prospectus, together with the information incorporated by reference therein, for more complete information about Tivic and the proposed offering.

Adamis Pharmaceuticals Announces Closing of $8.0 Million Public Offering

Retrieved on: 
Friday, August 4, 2023
Park Avenue, SEC filing, ADMP, Sale, Register, Prospectus, SAN, Form, Security (finance), Registration statement

Each unit was sold at a public offering price of $1.35.

Key Points: 
  • Each unit was sold at a public offering price of $1.35.
  • The common warrants are immediately exercisable at a price of $1.35 per share and expire five years from the date of issuance.
  • Gross proceeds, before deducting placement agent fees and other offering expenses, were approximately $8.0 million.
  • The offering was made only by means of a prospectus which is a part of the Registration Statement.